Our locations | Medicago

Medicago

Menu
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • fr
  • Our company
  • Our locations
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners

Our locations

Canadian Roots and Global Designs
  • Quebec | Canada

    Quebec City

    Medicago’s research, and product and process development activities are centralized in Quebec City, the most European city in North America, where the company operates three sites throughout the city.

    4,100  m2

    Its 3,000 m2 pilot plant is located alongside a 1,100 m2 greenhouse, while its headquarters, which also houses laboratories, is perched above the city.

    A new complex is currently under construction. The state-of-the-art facility, spreading out over 90,000 m2, will house the company’s new headquarters along with operations, R&D, production and all support functions. This new facility will be capable of providing up to 1 billion pandemic vaccine doses annually.

    Quebec City site
  • North Carolina | United States

    Raleigh-Durham

    Medicago established its U.S. subsidiary in the heart of Research Triangle Park (RTP) in North Carolina, strategically located between Miami and New York.

    14,500 m2

    The Triangle is the second-biggest cutting-edge tech hub in the U.S., after Silicon Valley, and the world’s largest research centre.

    Medicago works alongside more than 300 companies that employ about 55,000 people in R&D out of this facility.

    Medicago USA began its operations in 2010 through a partnership with the U.S. Defense Advanced Research Projects Agency (DARPA). This 14,500 m2 production unit houses a fully automated greenhouse and state-of-the-art extraction and purification system.

    Raleigh-Durham site
  • Ontario | Canada

    Toronto

    The dynamic metropolis of Toronto is the capital of Ontario and is conveniently located close to the U.S. border.

    In 2020, Medicago opened its new office just north of the City of Toronto near Pearson International Airport, an ideal location that easily accommodates not only employees but also visitors from around the world.

Medicago
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Legal
  • Privacy
  • Community guideline
  • Cookie policy
© Medicago Inc, 2022

This website uses cookies. Find out more

You are leaving a Medicago website

Medicago does not review or control the content of non-Medicago websites, and this link does not constitute an endorsement by Medicago of that site’s content.